Recurrent Non-small Cell Lung Cancer Withdrawn Phase 1 Trials for Sirolimus (DB00877)

Also known as: Non-Small Cell Lung Cancer Recurrent / Lung cancer non-small cell recurrent

IndicationStatusPhase
DBCOND0028805 (Recurrent Non-small Cell Lung Cancer)Withdrawn1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01383668Sirolimus and Gold Sodium Thiomalate in Treating Patients With Advanced Squamous Non-Small Cell Lung CancerTreatment
NCT02126527Auranofin and Sirolimus in Treating Patients With Advanced Solid Tumors or Recurrent Non-Small Cell Lung CancerTreatment